Specificity of Antisense Oligonucleotides in Vivo
Overview
Authors
Affiliations
Antisense oligonucleotides are widely used as inhibitors of gene expression in cultured cells and have been proposed as potential therapeutic agents, but it is not known to what extent they are specific for their intended target RNAs. Statistical considerations indicate that if oligonucleotides can form hybrids with mRNA molecules in vivo by means of short or imperfect regions of complementarity, then the specificity of oligonucleotides as antisense reagents will be greatly compromised. We have used Xenopus oocytes as a model system in which to investigate the potential specificity of antisense oligonucleotides in vivo. We injected perfect and partially matched antisense oligonucleotides into oocytes and measured the resulting degradation of the target RNA in each case. On the basis of the extent to which antisense oligonucleotides can cause cleavage of RNAs at imperfectly matched target sites, we conclude that in this system it is probably not possible to obtain specific cleavage of an intended target RNA without also causing at least the partial destruction of many nontargeted RNAs.
Koralewska N, Corradi E, Milewski M, Masante L, Szczepanska A, Kierzek R Nucleic Acids Res. 2024; 52(10):5804-5824.
PMID: 38676942 PMC: 11162791. DOI: 10.1093/nar/gkae284.
The prorenin receptor and its soluble form contribute to lipid homeostasis.
Gatineau E, Arthur G, Poupeau A, Nichols K, Spear B, Shelman N Am J Physiol Endocrinol Metab. 2021; 320(3):E609-E618.
PMID: 33459178 PMC: 7988779. DOI: 10.1152/ajpendo.00135.2020.
Watt A, Swayze G, Swayze E, Freier S Nucleic Acid Ther. 2020; 30(4):215-228.
PMID: 32125928 PMC: 7418465. DOI: 10.1089/nat.2020.0847.
Hybridization-mediated off-target effects of splice-switching antisense oligonucleotides.
Scharner J, Ma W, Zhang Q, Lin K, Rigo F, Bennett C Nucleic Acids Res. 2019; 48(2):802-816.
PMID: 31802121 PMC: 6954394. DOI: 10.1093/nar/gkz1132.
Smurf1 Silencing Using a LNA-ASOs/Lipid Nanoparticle System to Promote Bone Regeneration.
Garcia-Garcia P, Ruiz M, Reyes R, Delgado A, Evora C, Riancho J Stem Cells Transl Med. 2019; 8(12):1306-1317.
PMID: 31631568 PMC: 6877774. DOI: 10.1002/sctm.19-0145.